Home/Filings/4/0001562180-24-005118
4//SEC Filing

Goldan Keith A. 4

Accession 0001562180-24-005118

CIK 0001395937other

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 9:26 AM ET

Size

4.7 KB

Accession

0001562180-24-005118

Insider Transaction Report

Form 4
Period: 2024-06-14
Goldan Keith A.
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2024-06-14$20.03/sh+1,250$25,03752,623 total

Issuer

Syndax Pharmaceuticals Inc

CIK 0001395937

Entity typeother

Related Parties

1
  • filerCIK 0001495411

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 9:26 AM ET
Size
4.7 KB